Legend Biotech Corp Hybrid KOL Event Detailing Cartitude Data Update Call Transcript
Hello, and welcome to this Legend Biotech Investor Meeting, which we're holding on the sidelines of the 63rd Annual Meeting of the American Society of Hematology. I'm Tina Carter, Senior Manager of Corporate Communications and Investor Relations at Legend Biotech.
Before we begin, on these slides, you'll find our forward-looking statements. We encourage you to review this cautionary statement regarding information and remarks included in today's presentation as well as the company's Form 6-K which identifies certain factors that may cause our actual results to differ materially from those expressed in these forward-looking statements.
The information in this presentation speaks only as of the date hereof. Legend assumes no duty to update the information to reflect the subsequent developments. To see the progress and updates announced today in further detail, you can access our SEC filing and the presentation slides in the Investors section of legendbiotech.com.
On Slide 3, you'll find our disclosures. We
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
